Flushing Financial Logo 02-08-11 Blue 286.jpg
Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan
January 25, 2024 18:00 ET | Flushing Financial Corporation
Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively;
Whitelogolarge.jpg
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – HA, KRTX, EAR, ICVX
January 09, 2024 17:30 ET | Monteverde & Associates PC
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
ALERT: Juan Monteverde Encourages the Shareholders of CPE, FGH, EAR, BVH to Take Action
January 04, 2024 20:00 ET | Monteverde & Associates PC
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
SHAREHOLDER ALERT: Juan Monteverde Encourages the Shareholders of ICVX, EAR, CVLY, IMGN to Take Action
December 26, 2023 19:19 ET | Monteverde & Associates PC
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
ALERT: The M&A Class Action Firm Continues Investigating the Merger – EAR, IMGN, CVLY, EVFM
December 13, 2023 20:00 ET | Monteverde & Associates PC
NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – PATI, SLGC, JVA, EAR
November 17, 2023 20:00 ET | Monteverde & Associates PC
NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
STOCKHOLDER ALERT: Juan Monteverde Encourages the Shareholders of JVA, DOC, EAR, PATI to Take Action
November 10, 2023 20:00 ET | Monteverde & Associates PC
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Whitelogolarge.jpg
ALERT: Juan Monteverde Encourages the Shareholders of SRC, MIRO, DOC, EAR to Take Action
November 03, 2023 17:56 ET | Monteverde & Associates PC
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
MooreKuehn.jpg
Moore Kuehn Encourages CSTR, DOC, EAR, and SRC Investors to Contact Law Firm
November 01, 2023 10:12 ET | Moore Kuehn
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Cyclacel Pharmaceuticals logo
Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results
August 03, 2023 09:15 ET | Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...